Delaware's highest court ruled on Thursday that nearly 75,000 patients suing four large drugmakers cannot introduce reports ...

In the latest twist in the ocean of Zantac-related litigation playing out across state courts, drugmakers have notched a key ...

Delaware's top court reversed a ruling that allowed expert testimony in Zantac cancer lawsuits, citing improper legal ...

The Delaware Supreme Court rejected the legitimacy of expert testimony linking the heartburn drug Zantac to cancer, in a ...

Delaware's Supreme Court sides with drugmakers including GSK (GSK) and Pfizer (PFE), rejecting expert testimony linking ...

SANOFI has reached an agreement in principle to settle 4,000 US lawsuits linking the discontinued heartburn drug Zantac to cancer, the company said on Wednesday (Apr 3). Sanofi did not disclose the ...

First approved by US regulators in 1983, Zantac became the world’s best-selling medicine in 1988 and one of the first to top US$1 billion in annual sales.

Sanofi will pay more than US$100 million to settle about 4,000 lawsuits accusing the French drugmaker of failing to warn users that its Zantac heartburn medicine could cause cancer, according to ...

A jury in Chicago on Thursday rejected an Illinois woman’s claim that the now discontinued heartburn drug Zantac caused her colon cancer, in the first trial out of thousands of lawsuits making ...

(Reuters) -Lawyers for a man who alleges he developed bladder cancer after taking GSK Plc’s heartburn drug Zantac urged a California judge on Thursday to allow expert testimony linking the drug ...

The drug Zantac can elevate the risk of a person developing cancer. The active ingredient, ranitidine, contains a contaminant called NDMA, which is a probable human carcinogen. The above ...

More than 100,000 Zantac cases remain active in state courts around the country. The claim is not that Zantac (ranitidine)an antacid, per se, is dangerous.Rather, it is that, over time and intense ...